I can't see anything to suggest it's being looked at specifically. I've been reading Les and Teresa's letters, and the 2011-2012 FEWS reports.
The "ketamine analogues" are the ones I'd be worrying about. And ketamine itself, I would guess it'll be made class B.
Fucking hell, we are UK centric, aren't we?
IN THE UK